A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Clinical trial NCT01579461 · COMPLETED

Trial details

NCT number: NCT01579461
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Healthy Subjects Mild and Moderate Hepatic Impairment

Start date: 2008-11-01
Primary completion: 2009-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.